Merck's New Cholesterol Pill Gets A Boost
By no means is Merck (MRK) out of the woods yet, but there may be a clearing coming up. The pharmaceutical giant, which offers a 4.1% dividend yield, has been a leading player in cholesterol drugs for years. Its blockbuster Zocor is now generic, but Merck has since come out with Vytorin. Vytorin is a powerful drug. It's a combination of two drugs, Zocor and Zetia. It's a pricey drug, but the cocktail aims to better prevent heart attacks, strokes
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here